Ontario Power Generation's Response to the Joint Review
Ontario Power Generation's Response to the Joint Review
Ontario Power Generation's Response to the Joint Review
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
OPG’s L&ILW Deep Geologic Reposi<strong>to</strong>ry Project<br />
Tracking Tables for IR <strong>Response</strong>s, Design Updates and Corrections, Rev.3<br />
Section/Figure/Table in<br />
Document<br />
Sec. 14 References – Sec.4 <strong>Response</strong> <strong>to</strong><br />
Information Requests<br />
Appendix C,<br />
Sec. C1.1<br />
Appendix C,<br />
Sec. C2.3.1<br />
Appendix C,<br />
Sec. C2.7.5<br />
Appendix C –<br />
Attachment 1<br />
Temporal and<br />
Spatial Boundaries<br />
Environmental Impact Statement (00216-REP-07701-00001 R000)<br />
Information Type Scope of New Information Information Source CEAA<br />
Registry<br />
Item<br />
<strong>Response</strong> <strong>to</strong><br />
Information Requests<br />
Air Quality <strong>Response</strong> <strong>to</strong><br />
Information Requests<br />
Cancer Incidence <strong>Response</strong> <strong>to</strong><br />
Information Requests<br />
Human Health Risk<br />
Assessment<br />
<strong>Response</strong> <strong>to</strong><br />
Information Requests<br />
Updates edition of NBCC <strong>Response</strong> <strong>to</strong> IR-LPSC-01-01 in<br />
OPG <strong>Response</strong> <strong>to</strong> IR Package #1<br />
Letter dated Mar.9, 2012 [3]<br />
Provides additional information on<br />
spatial boundaries and scale<br />
Provides clarification on acrolein<br />
used as an input for human health<br />
Provides additional information on<br />
recep<strong>to</strong>r locations that best represent<br />
Métis communities<br />
Provides additional information on<br />
acrolein standards and results in<br />
respect of <strong>the</strong> new criteria<br />
Provides additional information on<br />
rationale for <strong>the</strong> interpretation of data<br />
on cancer incidence<br />
Provides clarification on assessment<br />
of <strong>the</strong> inhalation risk of acrolein <strong>to</strong><br />
persons on-site<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-03-45 in<br />
OPG <strong>Response</strong> <strong>to</strong> IR Package #3<br />
Letter dated Jul.9, 2012 [5]<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-01-09 in<br />
OPR <strong>Response</strong> <strong>to</strong> IR Package #1<br />
Letter dated Mar.9, 2012 [3]<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-03-69 in<br />
OPG <strong>Response</strong> <strong>to</strong> IR Package #3<br />
Letter dated Jul.9, 2012 [5]<br />
Submission of supplementary<br />
material <strong>to</strong> IR Package #1<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-01-09<br />
Letter dated Jul.10, 2012 [6]<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-03-89 in<br />
OPG <strong>Response</strong> <strong>to</strong> IR Package #3<br />
Letter dated Jul.9, 2012 [5]<br />
<strong>Response</strong> <strong>to</strong> IR-EIS-01-29 in<br />
OPG <strong>Response</strong> <strong>to</strong> IR Package #1<br />
Letter dated Mar.9, 2012 [3]<br />
363<br />
608<br />
363<br />
608<br />
606<br />
608<br />
363<br />
Page 33 of 138<br />
New